NCT04163562: Oral Immunotherapy for Peanut Allergic Patients
- State
- Under way
- Phase
- Phase 1 and Phase 2
- People
- 50 planned
- Started
- 11 Mar 2020
- Primary completion
- May 2025
- Arms
- INP20 (Oral Immunotherapy)
- Results
- None posted
- 14 Nov 2019: Trial registered
- 11 Mar 2020: Trial started